Literature DB >> 30204803

Heart rate variability as predictor of mortality in sepsis: A systematic review.

Fábio M de Castilho1, Antonio Luiz P Ribeiro1, Vandack Nobre1,2, Guilherme Barros1, Marcos R de Sousa1.   

Abstract

BACKGROUND: Autonomic dysregulation is one of the recognized pathophysiological mechanisms in sepsis, generating the hypothesis that heart rate variability (HRV) can be used to predict mortality in sepsis.
METHODS: This was a systematic review of studies evaluating HRV as a predictor of death in patients with sepsis. The search was performed by independent researchers in PubMed, LILACS and Cochrane, including papers in English, Portuguese or Spanish, indexed until August 20th, 2017 with at least 10 patients. Study quality was assessed by Newcastle-Ottawa Scale. To analyze the results, we divided the articles between those who measured HRV for short-term recordings (≤ 1 hour), and those who did long-term recordings (≥ 24 hours).
RESULTS: Nine studies were included with a total of 536 patients. All of them were observational studies. Studies quality varied from 4 to 7 stars in Newcastle-Ottawa Scale. The mortality rate in the studies ranged from 8 to 61%. Seven studies performed HRV analysis in short-term recordings. With the exception of one study that did not explain which group had the lowest results, all other studies showed reduction of several HRV parameters in the non-survivors in relation to the surviving septic patients. SDNN (Standard deviation of the Normal to Normal interval), TP (Total Power), VLF (Very Low Frequency Power), LF (Low Frequency Power), LF/HF (Low Frequency Power / High Frequency Power), nLF (Normalized Low Frequency Power), α1/α2 (short-term and long-term fractal scaling coefficients from DFA) and r-MSSD (Square root of the squared mean of the difference of successive NN-intervals) of the non-survivor group were reduced in relation to the survivors in at least one study. Two studies found that SDNN is associated with mortality in sepsis, even after adjusting for possible confounding factors. Three studies performed HRV analysis using long-term recordings. Only one of these studies found difference between surviving and non-surviving groups, and even so, in only one HRV parameter: LogHF.
CONCLUSIONS: Several HRV parameters are reduced in nonsurviving septic patients in short-term recording. Two studies have found that SDNN is associated with mortality in sepsis, even after adjusting for possible confounding factors.

Entities:  

Mesh:

Year:  2018        PMID: 30204803      PMCID: PMC6133362          DOI: 10.1371/journal.pone.0203487

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Sepsis, a syndrome in which there is dysregulated host response to infection and presence of organ dysfunction[1], has a high mortality rate that can vary between 10 and 50%[1, 2]. In addition to high lethality, its incidence has increased significantly in recent decades, making sepsis a serious global health problem [3]. For all these reasons, it is useful to identify the most serious septic patients through predictive scoring systems. Although autonomic dysregulation is one of the recognized pathophysiological mechanisms in sepsis[4], existing predictive scoring systems such as APACHE II (Acute Physiology and Chronic Health disease Classification System II)[5], SOFA (Sepsis-related Organ Failure Assessment)[6], SAPS-3 (Simplified Acute Physiology Score III)[7, 8] and MODS (Multiple Organ Dysfunction Score)[ do not considers in their composition changes in the autonomic nervous modulation. Physiological variation of heart rate indicates heart's capacity to adapt to different situations, and is influenced, among other factors, by the autonomic nervous system [10]. Heart rate variability (HRV) measures oscillations of the intervals between consecutive heart beats, being therefore a noninvasive indirect test to evaluate autonomic function [11]. Studies have shown that patients with sepsis have reduced HRV compared to healthy patients[12, 13]. Ahmad et al. demonstrated, in a small study, that patients with sepsis showed a significant drop in the value of several HRV parameters on average 35 hours before the diagnosis of sepsis[14]. These findings raised the possibility that the HRV can be used to predict the risk of developing sepsis or even for the diagnosis of sepsis. In addition to the diagnosis of sepsis, HRV parameter reduction seems to be related to worse outcomes in septic patients, and has a correlation with APACHE II and SOFA[15]. Finally, some studies have shown that HRV can be used to predict the risk of septic patients develop septic shock [16] and multiple organ dysfunction[17]. Recently, our research group published the results of a cohort study with septic patients in which several parameters of HRV were reduced in those patients who died in comparison to their counterparts. [18]. The objective of this study was to perform a systematic review of studies evaluating HRV as a predictor of death in patients with sepsis.

Materials and methods

Following the PRISMA statement [19] for systematic reviews and specific guidelines for nonrandomized studies [20], three bibliographic methods were used to identify potential abstracts or investigations: remote search in electronic databases; evaluation of bibliographic citations from hand search of texts; and email contact with authors (see S1 File for PRISMA Checklist and S2 File for PRISMA Flow Diagram). The databases used were PubMed, LILACS and Cochrane. Independent reviewers participated in the search and selection of studies. Two independent reviewers (FMC and GB) made the search and selection of studies in the databases, while MRS resolved any divergences. Additional articles were searched by citation tracking of review articles and original articles, and by looking for additional articles authored by the same authors of the papers previously selected. After analyzing titles and abstracts, the selected articles were read in full to confirm eligibility, and doubts or disagreements were solved through discussions with senior researchers (ALPR, VN and MRS). Inclusion criteria were clearly defined before the beginning of search. This systematic review has been registered within PROSPERO (the NIHR International Prospective Register of Systematic Reviews), under the registration number CRD42017062367. We included studies containing more than 10 patients which evaluated heart rate variability as predictor of mortality in sepsis, published before August 20th, 2017. Review studies and case series were excluded from this review. Publication languages included English, Portuguese and Spanish. The search-terms used were: "("Systemic Inflammatory Response Syndrome"[Mesh] OR "Systemic Inflammatory Response Syndrome" [All Fields] OR "Sepsis"[Mesh] OR "sepsis"[All Fields]) AND (("heart rate"[MeSH Terms] OR heart rate[Text Word]) AND (variability[Text Word] OR turbulence[All Fields]) OR "Nonlinear Dynamics"[Mesh] OR "Entropy"[Mesh] OR “triangular index”) AND (incidence[MeSH] OR mortality[MeSH] OR follow-up studies[MeSH] OR prognos*[Text Word] OR predict*[Text Word] OR course*[Text Word])”. Besides textual and MeSH terms selection, hand search within each paper’s references, and also "related citations", a search tool available in PubMed, were used to increase sensitivity of the search. Two researchers (MRS and FMC) independently double checked the extraction of primary data from each study. Discrepancies were solved by consensus after discussion with the remaining researchers. The following information was extracted: study design and methodological data; demographic and clinical characteristics of patients; number of patients who died and mean or median values of each HRV parameter in the surviving and non-surviving groups. The Newcastle-Ottawa Scale[21] was used to assess the quality of the included studies. Using this 'star system' (ranges from 0 to 9) each included study was judged on three broad perspectives, as recommended by the Cochrane Non-Randomized Studies Methods Working Group Version 5.1.0 [20, 22]: the selection of the study groups; the comparability of the groups; and the ascertainment of outcome of interest. To analyze the results, we divided the articles between those who measured HRV for short-term recordings (≤ 1 hour), and those who did long-term recordings (≥ 24 hours), since we know that long-term recording have different oscillatory components as compared to those of short duration[11]. One of the included studies contained the median value of SDNN for surviving and non-surviving groups, but did not report the p-value of the comparison between groups. So, we estimated the mean and standard deviation of SDNN of each group on basis of the sample’s reported median and range according to the method devised by S.P. Hozo, B. Djulbegovic, and I. Hozo[23]. Subsequently, SDNN of survivors and nonsurvivors were compared using the Student´s t test, conducted in SPSS version 23 (SPSS Inc., Chicago, IL, USA).

Results

The selection process and the inclusion flow of studies are shown in Fig 1. Nine studies were included, with a total of 536 patients [18, 24–31]. Table 1 shows the main methodological characteristics of the studies, and Table 2 reported the rate for each item of the Newcastle-Ottawa Scale, while Table 3 describes the methodologies used in each study to measure HRV.
Fig 1

Inclusion flow of studies.

Table 1

Characteristics of included studies.

Study(1st author/year)CountryEnrollmentperiodSample SizeAge(Mean)Male(%)Mortality EndpointMortality Rate (%)Definition of sepsisPopulation (Septic patients)Exclusion criteria
Tateishi 2007China2002 to 2005455471?29Infectious SIRSAdults in the ICUDM or neurological disease
Nogueira 2008Brasil2003 to 2005315174In-hospital mortality61Infectious SIRSAdults in the ICU receiving mechanical ventilationMI, nonsinusal rhythm, use of a permanent pacemaker, CHF class III or IV, or DM
Chen 2008Taiwan20061326747In-hospital mortality8Infectious SIRSAdults in the EDArrhythmia, cardiac pacing or respiratory failure under mechanical ventilator
Papaioannou 2009Greece2007 to 2008205876?20?Adults in the ICU receiving mechanical ventilationAtrial flutter or fibrillation, ventricular ectopic beats, use of anti-arrhythmic medication, severe brain injuries or acquired immunodeficiencies
Duque 2012Colombia2009 to 20101005558?40?Adults in the ICU with the need for cardiovascular or ventilatory supportClinical or electrocardioggraphic features complicating interpretation of the Holter recordings or coronary disease
Chen 2012Taiwan?64??24-hour mortality25Infectious SIRSAge- and sex-matched patients with sepsis in the ED used as the negative controlsPersistent arrhythmia or cardiac pacing
Brown 2013USA2009 to 201148574628-day mortality10Infectious SIRS>15 years of age patients in the ICU with severe sepsis or septic shockPregnancy or non-sinus rhythm
Cedillo 2015Spain2012336239In-hospital mortality18Infectious SIRSNon-smoking patients admitted to the wardMalignant diseases, CHF, nonsinusal rhythm, COPD, immunosuppression, use of beta or calcium-channel blockers, poorly-controlled DM, liver or renal failure or age > 80 years.
Castilho 2017Brasil2012 to 201463536028-day mortality25Infectious SIRSAdults in the ICUAntibiotic therapy for more than 48 hours prior to enrollment, nonsinus rhythm or with pacemaker

ICU = Intensive Care Unit; SIRS = Systemic Inflammatory Response Syndrome; ED = Emergency Department; DM = diabetes mellitus; MI = myocardial infarction; CHF = chronic heart failure; COPD = chronic obstructive pulmonary disease

Table 2

Newcastle-Ottawa Scale.

Study(1st author/year)Selection 1Selection 2Selection 3Selection 4ComparabilityOutcome 1Outcome 2Outcome 3Total Score
Tateishi 2007011101015
Nogueira 2008011101116
Chen 2008111101117
Papaioannou 2009110101004
Duque 2012111101106
Chen 2012011101015
Brown 2013111101117
Cedillo 2015010101104
Castilho 2017111101117
Table 3

HRV measurement in included studies.

Study(1st author/year)Duration of measurementRecording period used for analysisEquipmentRecording dayPatient´s conditions during recordWere there patients receiving Mechanical Ventilation?HRV parameters
Tateishi 200724-hour24-hourMonitorFirst and last?YesFrequency domain: LF, HF
Nogueira 200830-minute?Holter1,3 and 6Supine position, with ventilatory parameters completely controlled by the ventilatorAllFrequency domain: LF, HF, LF/HF
Chen 200810-minuteThe last 512 R-R intervalsECGFirstSupine position, room temperature around 25°CNoTime domain: SDNN, r-MSSD; Frequency domain: TP, VLF, LF, HF, nVLF, nLF, nHF and LF/HF
Papaioannou 200910-minute128 seconds time serieHolter?Supine positionAllTime domain: SDNN; Frequency domain: LF, HF, LF/HF; Nonlinear method: SD1/SD2
Duque 201248-hour?HolterFirst?YesTime domain: SDNN, pNN50
Chen 201210-minuteThe last 512 R-R intervalsECGFirst?YesTime domain: SDNN, CV; Frequency domain: TP, VLF, LF, HF, LF/HF
Brown 20136-hourFirst 30minutesMonitorFirst?YesTime domain: NN, SDNN, r-MSSD, pNN50, NN50; Frequency domain: TP, LF, HF, LF/HF; Nonlinear methods: SD1/SD2, Sample entropy, DFA short-term coefficient, DFA long-term coefficient, Ratio of DFA coefficients
Cedillo 201515-minuteThe last 512 R-R intervalsECGFirstSupine position after a 10-min resting period and normal breathingNoTime domain: r-MSSD; Frequency domain: TP, LF, HF, LF/HF
Castilho 201720-minute and 24-hourFirst 10 minutesHolterFirstSupine position and no intervention was made during its recordingYesTime domain: NN, SDNN, r-MSSD, pNN50; Frequency domain: TP, VLF, LF, HF, LF/HF

LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nVLF = Normalized Very Low Frequency; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; pNN50 = Percentage of NN intervals deviated by more than 50 ms from adjacent NN-intervals; NN50 = Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording; SD1 = Poincare standard deviation 1; SD2 = Poincare standard deviation 2; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation

ICU = Intensive Care Unit; SIRS = Systemic Inflammatory Response Syndrome; ED = Emergency Department; DM = diabetes mellitus; MI = myocardial infarction; CHF = chronic heart failure; COPD = chronic obstructive pulmonary disease LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nVLF = Normalized Very Low Frequency; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; pNN50 = Percentage of NN intervals deviated by more than 50 ms from adjacent NN-intervals; NN50 = Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording; SD1 = Poincare standard deviation 1; SD2 = Poincare standard deviation 2; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation Study quality analysis by the Newcastle-Ottawa Scale showed that, in general, studies were representative of the sampled population, varying from 4 to 7 stars (mean 5.7). Except for the study of Chen and cols. 2012[27], in which patients with sepsis were included as controls of successfully resuscitated patients with out-of-hospital cardiac arrest (the main population of interest in the study), all other studies were prospective cohorts primary designed to include/primary focused on septic patients. One of the studies[25] was a combined prospective cohort and case-control study. The cohort group consisted of 33 septic patients, and these were the data we used in this review. Regarding the diagnostic criteria for sepsis used in each study, in two studies[28, 30] this information is not clearly reported, while in the other 7 studies[18, 24–27, 29, 31] the presence of infection and SIRS was used as the diagnostic criteria. Of these seven studies, two[24, 31] use the 1992 Consensus[32], while five[18, 25–27, 29] use the 2001 consensus[33]. Taken as whole, the included studies measured the following HRV parameters in the time domain: Normal-to-Normal (NN) average interval, Standard deviation of the NN interval (SDNN), Square root of the squared mean of the difference of successive NN-intervals (r-MSSD), Percentage of NN intervals deviated by more than 50 ms from adjacent NN-intervals (pNN50), Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording (NN50), Coefficient of variation (CV); frequency domain: Low Frequency Power (LF), High Frequency Power (HF), ratio of LF to HF (LF/HF), Total Power (TP), Very Low Frequency Power (VLF), Normalized Very Low Frequency (nVLF), Normalized Low Frequency Power (nLF) and Normalized High Frequency Power (nLF); nonlinear methods: Poincare standard deviation 1 (SD1), Poincare standard deviation 2 (SD2), Short-term (α1) and long-term (α2) fractal scaling coefficients from Detrended Fluctuation Analysis (DFA). Of the nine studies included in this systematic review, five make explicit the realization of some type of treatment for artifacts (period selection without artifact, manual deletion of artifacts, deletion of record if it presents artifact percentage greater than a predetermined value etc.). The way this was done in each study can be seen in the S1 Table. The small number of studies, their technical limitations and its great heterogeneity prevented a meta-analysis to be performed. Some studies only presented HRV results in graphs [29, 31] or summary descriptions in the body of the article[24, 25, 30], without informing the central value of each HRV parameter in the surviving and non-surviving groups. The outcome of one study was 24-hour mortality[27], not allowing comparison with the other studies, which assessed mortality at longer time interval: 28-day mortality in two studies[18, 24], the in-hospital mortality in three studies[25, 26, 29] and, although the time at which endpoint mortality is assessed is unclear in the remaining three studies[28, 30, 31], the presented data strongly suggest that the follow-up for this outcome was longer than 24h, probably being in-ICU mortality. There was also a large difference in the population evaluated in the included studies: for instance, while two of the studies excluded mechanically ventilated patients[25, 26], two other studies restricted their analysis to patients who were on mechanical ventilation[29, 30]. The mortality rate observed in the different studies varied considerably, ranging from 8 to 61%, probably indicating a difference in clinical spectrum among populations. Seven studies performed HRV analysis in short-term recordings (≤ 1 hour) [18, 24–27, 29, 30], Three studies performed HRV analysis using long-term recordings (≥ 24 hours) [18, 28, 31]. One of the articles [24] did an intermediate period recording (6 hours), but in this paper HRV analysis was restricted to the first 30 minutes of recording. Therefore, this study was included in the short-term recording (<1 hour) group. We did not find any article that did HRV analysis for period between 1 hour and 24 hours. The main results of these studies are presented in Table 4 and Table 5, respectively. One of the studies made both a recording of short duration (20 minutes) and another one of long duration (24 hours)[18].
Table 4

Main results in short time record studies.

Study(1st author/year)Duration of measurementDoes it show the values (mean or median) of HRV parameters in the surviving and non-survivors groups?How are the results presented?HRV parameters of nonsurvivors lower than those of survivors*HRV parameters of nonsurvivors higher than those of survivors*Additional results / Comments
Nogueira 200830-minuteNoGraph comparing LF, HF e LF/HF between surviving and non-surviving patients.LF, HF and LF/HF
Chen 200810-minuteYesTable with HRV parameters values for surviving and non-surviving groupsSDNN, TP, VLF, LF and LF/HFnHFMultiple logistic regression model identified SDNN and nHF as the significant independent variables in the prediction mortality.
Papaioannou 200910-minuteNoOnly citation in the text of the articleThe natural logarithms of SDNN, LF and HF were significantly different between survivors and non-survivors, but there is no information on which patient group had the highest values.
Chen 201210-minuteYesTable with HRV parameters values for surviving and non-surviving groupsnLF, and LF/HFnHF and HF
Brown 201330-minuteNoOnly citation in the text of the articleα1/α2
Cedillo 201515-minuteNoOnly citation in the text of the articler-MSSD and nHF
Castilho 201720-minuteYesTable with HRV parameters values for surviving and non-surviving groupsSDNN, TP, VLF, LF and LF/HFSDNN ≤17 is a risk factor for death in septic patients, even after adjusting for APACHE II or SOFA.

* = Only results with statistical significance were shown

LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation; α1/α2 = short-term and long-term fractal scaling coefficients from DFA

Table 5

Main results in long time record studies.

Study(1st author/year)Duration of measurementDoes it show the values of HRV parameters in the surviving and non-survivors groups?How are the results presented?HRV parameters of nonsurvivors lower than those of survivors*HRV parameters of nonsurvivors higher than those of survivors*Additional results / Comments
Tateishi 200724-hourNoGraph comparing logLF and logHF between surviving and non-surviving patientsLogHF
Duque 201248-hourYesTable with SDNN and PNN50 values for surviving and non-surviving groupsMedian SDNN non significantly higher in the surviving group than in the nonsurvivor group (72.5ms [IQR 42] vs 61ms [IQR 65],p value not reported in the article, but we calculated p = 0.272)
Castilho 201724-hourYesTable with HRV parameters values for surviving and non-surviving groupsThere was no statistically significant difference in any HRV parameter measured in the 24 hours Holter between the two subgroups

* = Only results with statistical significance were shown

Log = logarithm; LF = Low Frequency Power; HF = High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval

* = Only results with statistical significance were shown LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation; α1/α2 = short-term and long-term fractal scaling coefficients from DFA * = Only results with statistical significance were shown Log = logarithm; LF = Low Frequency Power; HF = High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval Regarding the studies that used short term recordings to measure HRV, one of them reported a statistically significant difference of SDNN, LF and HF values between survivors and non-survivors, but authors did not inform which patient group had the highest values, what does not allow a deeper analysis of these results and comparison with other studies[30]. The remaining studies (n = 6) showed reduction of several HRV parameters in the non-survivors in relation to the surviving septic patients: SDNN[18, 26], TP[18, 26], VLF[18, 26], LF[18, 26, 29], LF/HF ratio[18, 26, 27, 29], nLF[27], α1/α2[24] and r-MSSD[25]. From these studies, four did not show the exact central value (mean or median) of the HRV parameters in survivor and non-survivor groups, presenting the results only in graphics or summarized in the body of the article. Chen et al, through the multiple logistic regression model, found that SDNN was a significant independent variable in the prediction of mortality in sepsis, with odds ratio of 0.719 (0.537–0.962), p = 0.026 [26]. Castilho et al defined a cut-off point for the SDNN of 17ms and found that Cox regression for dichotomous SDNN adjusted by the APACHE II showed Hazard ratio (HR) of 5.5 (1.2±24.8; p = 0.027) and Cox regression for this dichotomous variable adjusted by the SOFA showed HR of 6.3 (1.4±28.0; p = 0.015) [18]. There was a contradiction in the outcome prediction of HF and nHF, where some studies showed that their values were reduced in the non-survivor group [25, 29], while other studies showed higher values of these parameters were in the same group [26, 27]. From the studies using long-term recordings, only one article found statistically significant differences of any HRV parameter between survivors and non-survivors: LogHF was higher in the non-survivor than the survivor group[31]. The other two articles found no statistically significant differences between survivors and non-survivors for any HRV parameter[18, 28].

Discussion

In this systematic review, we found that HRV parameters measured in short-term recordings were reduced in septic patients who died in relation to those who survived. This finding raises the possibility that HRV measurement can be a useful tool to predict the risk death in sepsis. On the other hand, there was no clear evidence of association between HVR parameters in long-term recordings and sepsis outcome. There have has been an increasing interest in the role played by the autonomic nervous system in the complexes mechanisms involved in sepsis physiopathology. It is known, for example, that vagus nerve stimulation increases the secretion of corticotropin-releasing hormone, ACTH and cortisol[34]; it has been demonstrated that vagotomy attenuates fever response[35]; and that acetylcholine, the main vagal neurotransmitter, has an anti-inflammatory effect, attenuating the release of cytokines such as TNF, IL-1beta, IL-6 and IL-18, and preventing the development of shock[36]. Taken together, these findings suggest that the autonomic nervous system is involved in peripheral cytokine-to-brain communication, participating in the pathophysiology of sepsis. Based on these results, some authors have investigated if the measurement of HRV, a noninvasive indirect test to evaluate autonomic function, in septic patients could be useful to predict outcome in these patients. HRV is measured using simple and non-invasive methods, requiring automated devices available on the market. Therefore, HRV is considered one of the most popular methods used to evaluate the autonomic function, being suitable for use in emergency department, ward or intensive care settings, where septic patients are usually taken[11]. The seven studies that analyzed HRV in short-term recordings[18, 24–27, 29, 30] showed significant difference between groups of surviving and non-surviving septic patients regarding different parameters. Except for one study that did not report which group had the highest value[30], the other six studies showed a reduction of at least one HRV parameter in the group of patients who died. These findings suggest that loss of heart rate oscillatory capacity, controlled, among other factors, by the autonomic nervous system is related to the severity of sepsis and risk of death. The only conflicting results revealed by this systematic review referred to the HF Power, which was shown to be reduced in the non-survivor group in some studies, but increased in others. HF Power reflects the vagal activity (parasympathetic) on the sinus node[37]. Different factors could explain the conflicting results for HF Power, such as the fact that the studies have small samples, the heterogeneity of the populations (some only with patients on mechanical ventilation, others only with patients on spontaneous ventilation, for example) or the presence of artifacts in electrocardiographic records. Of the nine studies included in this systematic review, five make explicit the realization of some type of treatment for artifacts. Studies show that the presence of artifacts or different treatment given to them may inflate the HRV analysis result[38, 39]. Among all HRV parameters tested to predict risk of death in sepsis, several parameters in both time domain and frequency domain have been shown to be reduced in non-surviving septic patients. More studies are needed to define which HRV parameters are most useful to predict mortality in sepsis and which cut-off values of each parameter should be used. [18, 26, 27, 29][18, 26]However, the SDNN stands out in the studies carried out until now, because two studies found this parameter as being associated with sepsis mortality, even after adjusting for possible confounding factors[18, 26] and one of these studies have even tested a cut-off point for this parameter[18]. SDNN seems to reflect all the cyclic components responsible for HRV (including sympathetic and parasympathetic activity)[11]. Some studies used the ICU monitors themselves to perform the electrocardiographic recording[24, 31], assuming that, through the implementation of SDNN calculation software, the ICU monitors themselves could calculate the SDNN of septic patients as a measure of the risk of death. Only one [31] from the three [18, 28, 31] studies that analyzed long-term recordings for HRV found differences between surviving and non-surviving groups, and even so, in only one HRV parameter. We believe that the difficulty of association between HRV parameters and mortality in sepsis in long-term recordings is due, among other factors, to the dynamic condition of sepsis, in which metabolic disturbances, hemodynamic and ventilatory evolutionmay interfere with HRV parameters. In short-term recordings, it is possible to keep the patient in a specific position (supine, for example) and keep the patient without interventions such as orotracheal aspiration, which could interfere with HRV. Furthermore, in critical care patients, shorter periods of recording minimizes the interference with ICU routine activities, and have the advantage of being a fast tool for definition of severity, as these patients present immediate risk of death.

Study limitations

The main limitation of this systematic review is the low number and quality of the studies included. The great heterogeneity of the HRV recording and analysis methods used, as well as the great heterogeneity of the population of each study prevented us to perform a meta-analysis. Other limitations are the low number of patients in each study and the fact that all of them were unicentric. Thus, although it is possible to affirm that a reduction in HRV fall seems to be related to sepsis mortality, it would be necessary to perform a larger, preferably multicenter study, to define the best HVR recordings and analysis methodology, as well as what parameters and cutoff points should be adopted to predict the risk of death.

Conclusions

Several HRV parameters are reduced in nonsurviving septic patients in short-term recording. SDNN seems to be independently associated with mortality in sepsis, emerging as a useful HRV parameter to predict sepsis outcome. These findings need to be confirmed in larger well-designed studies.

PRISMA checklist.

(DOC) Click here for additional data file.

PRISMA flow diagram.

(DOC) Click here for additional data file.

Treatment for artifacts used in each study.

(DOC) Click here for additional data file.
  36 in total

1.  Ectopic beats in heart rate variability analysis: effects of editing on time and frequency domain measures.

Authors:  M A Salo; H V Huikuri; T Seppänen
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-01       Impact factor: 1.468

Review 2.  Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology.

Authors:  Eliano Pio Navarese; Marek Koziński; Teodosio Pafundi; Felicita Andreotti; Antonino Buffon; Stefano De Servi; Jacek Kubica
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Spectral analysis of heart period and pulse transit time derived from electrocardiogram and photoplethysmogram in sepsis patients.

Authors:  Collin H H Tang; Gregory S H Chan; Paul M Middleton; Andrey V Savkin; Nigel H Lovell
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

5.  Usefulness of α7 nicotinic receptor messenger RNA levels in peripheral blood mononuclear cells as a marker for cholinergic antiinflammatory pathway activity in septic patients: results of a pilot study.

Authors:  José L Cedillo; Francisco Arnalich; Carolina Martín-Sánchez; Angustias Quesada; Juan José Rios; María C Maldifassi; Gema Atienza; Jaime Renart; Carmen Fernández-Capitán; Francisco García-Rio; Eduardo López-Collazo; Carmen Montiel
Journal:  J Infect Dis       Date:  2014-08-04       Impact factor: 5.226

Review 6.  Basic notions of heart rate variability and its clinical applicability.

Authors:  Luiz Carlos Marques Vanderlei; Carlos Marcelo Pastre; Rosângela Akemi Hoshi; Tatiana Dias de Carvalho; Moacir Fernandes de Godoy
Journal:  Rev Bras Cir Cardiovasc       Date:  2009 Apr-Jun

7.  Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients.

Authors:  Yoshihisa Tateishi; Shigeto Oda; Masataka Nakamura; Keisuke Watanabe; Tomoyuki Kuwaki; Takeshi Moriguchi; Hiroyuki Hirasawa
Journal:  Shock       Date:  2007-11       Impact factor: 3.454

8.  Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability.

Authors:  Antonio Carlos Nogueira; Victor Kawabata; Paolo Biselli; Marcelo Henrique Lins; Carla Valeri; Mauricio Seckler; Wagner Hoshino; Luiz Gonzaga Júnior; Marcia Martins Silveira Bernik; Juliana B de Andrade Machado; Marina Baquerizo Martinez; Paulo Andrade Lotufo; Elia Garcia Caldini; Edgair Martins; Rui Curi; Francisco Garcia Soriano
Journal:  Shock       Date:  2008-03       Impact factor: 3.454

Review 9.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

10.  Heart rate variability as predictor of mortality in sepsis: A prospective cohort study.

Authors:  Fábio M de Castilho; Antonio Luiz P Ribeiro; José Luiz P da Silva; Vandack Nobre; Marcos R de Sousa
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

View more
  18 in total

1.  Autonomic Disbalance During Systemic Inflammation is Associated with Oxidative Stress Changes in Sepsis Survivor Rats.

Authors:  Mateus R Amorim; Aline A de Jesus; Nilton N Santos-Junior; Maria J A Rocha; Jonatas E Nogueira; Marcelo E Batalhão; Evelin C Cárnio; Luiz G S Branco
Journal:  Inflammation       Date:  2022-01-04       Impact factor: 4.092

2.  Evaluation of a wrist-worn photoplethysmography monitor for heart rate variability estimation in patients recovering from laparoscopic colon resection.

Authors:  Juha K A Rinne; Seyedsadra Miri; Niku Oksala; Antti Vehkaoja; Jyrki Kössi
Journal:  J Clin Monit Comput       Date:  2022-04-08       Impact factor: 2.502

3.  Continuous heart rate variability and electroencephalography monitoring in severe acute brain injury: a preliminary study.

Authors:  Hyunjo Lee; Sang-Beom Jeon; Kwang-Soo Lee
Journal:  Acute Crit Care       Date:  2021-03-18

Review 4.  Objectifying the Subjective: The Use of Heart Rate Variability as a Psychosocial Symptom Biomarker in Hospice and Palliative Care Research.

Authors:  Mallory R Taylor; Samantha R Scott; Angela Steineck; Abby R Rosenberg
Journal:  J Pain Symptom Manage       Date:  2021-04-29       Impact factor: 5.576

Review 5.  A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment.

Authors:  Ariel Kenig; Yaron Ilan
Journal:  Front Physiol       Date:  2019-12-19       Impact factor: 4.566

6.  Heart rhythm complexity as predictors for the prognosis of end-stage renal disease patients undergoing hemodialysis.

Authors:  Hongyun Liu; Ping Zhan; Jinlong Shi; Minlu Hu; Guojing Wang; Weidong Wang
Journal:  BMC Nephrol       Date:  2020-12-09       Impact factor: 2.388

7.  Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity.

Authors:  Alessandro Maloberti; Nicola Ughi; Davide Paolo Bernasconi; Paola Rebora; Iside Cartella; Enzo Grasso; Deborah Lenoci; Francesca Del Gaudio; Michela Algeri; Sara Scarpellini; Enrico Perna; Alessandro Verde; Caterina Santolamazza; Francesco Vicari; Maria Frigerio; Antonia Alberti; Maria Grazia Valsecchi; Claudio Rossetti; Oscar Massimiliano Epis; Cristina Giannattasio
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

Review 8.  A narrative review of heart rate and variability in sepsis.

Authors:  Benjamin Yi Hao Wee; Jan Hau Lee; Yee Hui Mok; Shu-Ling Chong
Journal:  Ann Transl Med       Date:  2020-06

9.  Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients.

Authors:  Yu-Ming Chang; Ya-Ting Huang; I-Ling Chen; Chuan-Lan Yang; Show-Chin Leu; Hung-Li Su; Jsun-Liang Kao; Shih-Ching Tsai; Rong-Na Jhen; Chih-Chung Shiao
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

Review 10.  Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death.

Authors:  César Caraballo; Fabián Jaimes
Journal:  Yale J Biol Med       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.